Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The RadNet, Inc. (RDNT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a NASDAQ-listed issuer. RadNet files reports and current updates with the U.S. Securities and Exchange Commission in connection with its operations as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of the DeepHealth digital health division.
Among the filings that investors commonly review are annual reports on Form 10-K and quarterly reports on Form 10-Q, which present information on RadNet’s Imaging Center and Digital Health reportable segments, revenue composition, imaging volumes, liquidity and capital structure. Current reports on Form 8-K are used to disclose specific material events, such as the release of quarterly financial results or the filing of a prospectus supplement under an automatic shelf registration statement. For example, RadNet has filed 8-Ks to furnish press releases detailing financial results for quarters ended June 30, 2025 and September 30, 2025, and to report the filing of a prospectus supplement registering shares of common stock for resale by selling stockholders.
Through this filings page, users can also monitor documents related to securities offerings, including prospectus supplements and associated legal opinions, as well as other disclosures that may affect the company’s capital markets activity. Forms related to insider transactions, such as Form 4, and proxy materials on executive compensation and governance are part of the broader SEC record and can be relevant for understanding management incentives and ownership changes.
Stock Titan enhances access to these filings by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that explain key points in plain language. This can help readers interpret lengthy documents such as 10-K and 10-Q reports, understand the implications of 8-K announcements and quickly identify notable items in RadNet’s regulatory history. For anyone analyzing RDNT, the SEC filings page is a central source for official, time-stamped information on the company’s financial condition, segment performance and capital markets activity.
Form 144 notice for RadNet, Inc. (RDNT): The filer notified the SEC of a proposed sale of 35,000 common shares on 09/15/2025 through Merrill Lynch (Chandler, AZ) on NASDAQ, with an aggregate market value of $2,590,350.00. The shares were acquired as equity compensation in multiple grants dated between 01/02/2014 and 01/03/2017, totaling listed lots of 8,353; 12,018; 12,982; 1,638; and 9 shares. The filer reports no securities sold in the past three months for the account. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
RadNet, Inc. (RDNT) director/officer Wesdorp Cornelis reported a sale of company common stock. The Form 4 shows a transaction on 09/11/2025 in which 500 shares were sold at $72.13, leaving Mr. Wesdorp with 53,495 shares beneficially owned in a direct ownership form. The filing was signed by an attorney-in-fact, Jose Gamez, on 09/12/2025.
Form 144 notice for RadNet, Inc. (RDNT) shows a proposed sale of 500 shares of common stock through APEX Clearing on 09/11/2025. The shares were acquired by the seller as compensation on 10/01/2024. The filing reports an aggregate market value of $36,865 for the proposed sale and lists 76,916,062 shares outstanding for the class.
The notice also discloses recent sales by the same person: 1,500 shares sold on 08/19/2025 for $100,470 and 500 shares sold on 09/09/2025 for $35,995. The filer certifies they are not aware of undisclosed material adverse information about the issuer and includes the standard Rule 144 representations and warnings about intentional misstatements.
RadNet, Inc. (RDNT) notice: an individual plans to sell 10,000 common shares through Raymond James on 09/10/2025 on NASDAQ for an aggregate market value of $726,892.00. The shares were originally acquired as restricted stock units on 05/02/2017 and paid for in cash. The filer reports 76,916,062 shares outstanding for the class and discloses no sales by the seller in the past three months. The form includes the standard representation that the seller is not aware of undisclosed material adverse information and the required signature/notice language.
On 09/09/2025, Cornelis Wesdorp, President & CEO, Digital Health at RadNet, Inc. (RDNT) reported a sale of 500 shares of the issuer's common stock at a price of $71.99 per share. After this transaction Wesdorp beneficially owned 53,995 shares directly. The Form 4 was signed by an attorney-in-fact on 09/10/2025. No derivative transactions or additional explanatory details were provided.
Form 144 notice for RadNet, Inc. (RDNT) reporting a proposed sale of 2,000 common shares through APEX Clearing valued at $145,460. The filing shows approximate sale date 08/19/2025 and reports 76,916,062 shares outstanding. The 2,000 shares were acquired from the issuer on 10/01/2024 as compensation (1,500 and 500 units recorded separately). The filing also records a sale on 08/19/2025 by Cornelis Wesdorp of 1,500 shares for $100,470. The notice includes the required representation that the seller is not aware of undisclosed material adverse information and contains the standard signature and legal attestation language.
RadNet insider sale: On 08/27/2025, Norman R. Hames, President and COO - West Operations, reported selling 5,000 shares of RadNet, Inc. common stock at $71.10 per share. After the transaction he is reported to beneficially own 19,889 shares indirectly through his spouse. The Form 4 was signed by an attorney-in-fact on 08/29/2025 and contains no derivative transactions or additional amendments.
RadNet, Inc. (RDNT) Form 144 notice: The filer proposes to sell 5,000 shares of common stock through Raymond James (9595 Wilshire Blvd., Suite 801, Beverly Hills, CA) with an approximate aggregate market value of $358,950. The proposed sale date is 08/27/2025 on NASDAQ. The filing reports 76,916,062 shares outstanding. All 5,000 shares were acquired as stock awards from the issuer on 01/28/2021 (864 shares), 02/18/2021 (1,205 shares) and 01/05/2022 (2,931 shares), and payment/nature of acquisition is listed as Stock Award. The form contains no reportable sales in the past three months. Several standard filer and issuer identification fields (CIK, issuer name and contact details) are not provided in the visible content.
Insider sale recorded: Cornelis Wesdorp, listed as President & CEO, Digital Health and a director of RadNet, Inc. (RDNT), reported selling 1,500 shares of common stock on 08/19/2025 at a price of $66.98 per share. After the sale he beneficially owned 54,495 shares in a direct form. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
RadNet insider transaction: The company's Chief Information Officer reported a sale of 65,598 shares of RadNet common stock at $67.50 per share, leaving beneficial ownership of 138,198 shares after the reported transaction. The Form 4 indicates the filing was submitted by a single reporting person and signed by an attorney-in-fact.